MAC COPPER LTD (MTAL) Fundamental Analysis & Valuation

NYSE:MTAL • JE00BQBC8469

Current stock price

12.21 USD
0 (0%)
At close:
12.22 USD
+0.01 (+0.08%)
After Hours:

This MTAL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. MTAL Profitability Analysis

1.1 Basic Checks

  • In the past year MTAL has reported negative net income.
  • In the past year MTAL had a positive cash flow from operations.
  • MTAL had negative earnings in 4 of the past 5 years.
  • MTAL had negative operating cash flow in 4 of the past 5 years.
MTAL Yearly Net Income VS EBIT VS OCF VS FCFMTAL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -6.05%, MTAL is doing worse than 64.10% of the companies in the same industry.
  • With a Return On Equity value of -17.03%, MTAL is not doing good in the industry: 69.23% of the companies in the same industry are doing better.
  • MTAL has a Return On Invested Capital of 5.65%. This is in the better half of the industry: MTAL outperforms 65.38% of its industry peers.
Industry RankSector Rank
ROA -6.05%
ROE -17.03%
ROIC 5.65%
ROA(3y)-6.21%
ROA(5y)N/A
ROE(3y)-23.53%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MTAL Yearly ROA, ROE, ROICMTAL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -10 -20 -30 -40 -50

1.3 Margins

  • The Operating Margin of MTAL (22.68%) is better than 75.00% of its industry peers.
  • MTAL has a Gross Margin of 31.07%. This is in the better half of the industry: MTAL outperforms 69.23% of its industry peers.
Industry RankSector Rank
OM 22.68%
PM (TTM) N/A
GM 31.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MTAL Yearly Profit, Operating, Gross MarginsMTAL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. MTAL Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MTAL is destroying value.
  • MTAL has more shares outstanding than it did 1 year ago.
  • The debt/assets ratio for MTAL has been reduced compared to a year ago.
MTAL Yearly Shares OutstandingMTAL Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M
MTAL Yearly Total Debt VS Total AssetsMTAL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 500M 1B

2.2 Solvency

  • MTAL has an Altman-Z score of 0.70. This is a bad value and indicates that MTAL is not financially healthy and even has some risk of bankruptcy.
  • MTAL's Altman-Z score of 0.70 is on the low side compared to the rest of the industry. MTAL is outperformed by 83.33% of its industry peers.
  • The Debt to FCF ratio of MTAL is 7.26, which is on the high side as it means it would take MTAL, 7.26 years of fcf income to pay off all of its debts.
  • MTAL's Debt to FCF ratio of 7.26 is fine compared to the rest of the industry. MTAL outperforms 66.03% of its industry peers.
  • A Debt/Equity ratio of 0.68 indicates that MTAL is somewhat dependend on debt financing.
  • MTAL has a worse Debt to Equity ratio (0.68) than 82.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 7.26
Altman-Z 0.7
ROIC/WACC0.54
WACC10.47%
MTAL Yearly LT Debt VS Equity VS FCFMTAL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • A Current Ratio of 0.58 indicates that MTAL may have some problems paying its short term obligations.
  • With a Current ratio value of 0.58, MTAL is not doing good in the industry: 91.67% of the companies in the same industry are doing better.
  • MTAL has a Quick Ratio of 0.58. This is a bad value and indicates that MTAL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • MTAL's Quick ratio of 0.45 is on the low side compared to the rest of the industry. MTAL is outperformed by 90.38% of its industry peers.
Industry RankSector Rank
Current Ratio 0.58
Quick Ratio 0.45
MTAL Yearly Current Assets VS Current LiabilitesMTAL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. MTAL Growth Analysis

3.1 Past

  • MTAL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 65.56%, which is quite impressive.
  • MTAL shows a strong growth in Revenue. In the last year, the Revenue has grown by 114.30%.
EPS 1Y (TTM)65.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.27%
Revenue 1Y (TTM)114.3%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.39%

3.2 Future

  • Based on estimates for the next years, MTAL will show a very strong growth in Earnings Per Share. The EPS will grow by 89.23% on average per year.
  • The Revenue is expected to grow by 12.12% on average over the next years. This is quite good.
EPS Next Y270.09%
EPS Next 2Y183.08%
EPS Next 3Y104.94%
EPS Next 5Y89.23%
Revenue Next Year6.2%
Revenue Next 2Y15.2%
Revenue Next 3Y12.29%
Revenue Next 5Y12.12%

3.3 Evolution

MTAL Yearly Revenue VS EstimatesMTAL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
MTAL Yearly EPS VS EstimatesMTAL Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 0 1 -1 2

More info and screens

Find the best growth stocksShow best growing peers

6

4. MTAL Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MTAL. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 10.66, the valuation of MTAL can be described as reasonable.
  • MTAL's Price/Forward Earnings ratio is rather cheap when compared to the industry. MTAL is cheaper than 83.97% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.51. MTAL is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 10.66
MTAL Price Earnings VS Forward Price EarningsMTAL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

  • 83.33% of the companies in the same industry are more expensive than MTAL, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, MTAL is valued cheaper than 86.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.49
EV/EBITDA 8.18
MTAL Per share dataMTAL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

  • MTAL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • MTAL's earnings are expected to grow with 104.94% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y183.08%
EPS Next 3Y104.94%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MTAL Dividend Analysis

5.1 Amount

  • MTAL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

MTAL Fundamentals: All Metrics, Ratios and Statistics

MAC COPPER LTD

NYSE:MTAL (10/10/2025, 8:45:28 PM)

After market: 12.22 +0.01 (+0.08%)

12.21

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)07-23
Earnings (Next)10-20
Inst Owners35.58%
Inst Owner Change0%
Ins Owners0.31%
Ins Owner ChangeN/A
Market Cap1.01B
Revenue(TTM)340.74M
Net Income(TTM)-81.69M
Analysts77.78
Price Target12.5 (2.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-17.99%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-23.59%
EPS NY rev (1m)-51.89%
EPS NY rev (3m)-52.08%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.66
P/S 2.95
P/FCF 19.49
P/OCF 8.32
P/B 2.1
P/tB 2.1
EV/EBITDA 8.18
EPS(TTM)-0.99
EYN/A
EPS(NY)1.14
Fwd EY9.38%
FCF(TTM)0.63
FCFY5.13%
OCF(TTM)1.47
OCFY12.01%
SpS4.13
BVpS5.82
TBVpS5.82
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.05%
ROE -17.03%
ROCE 7.16%
ROIC 5.65%
ROICexc 6.28%
ROICexgc 6.28%
OM 22.68%
PM (TTM) N/A
GM 31.07%
FCFM 15.16%
ROA(3y)-6.21%
ROA(5y)N/A
ROE(3y)-23.53%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 7.26
Debt/EBITDA 2.11
Cap/Depr 88.98%
Cap/Sales 20.34%
Interest Coverage 1.86
Cash Conversion 77.97%
Profit Quality N/A
Current Ratio 0.58
Quick Ratio 0.45
Altman-Z 0.7
F-Score6
WACC10.47%
ROIC/WACC0.54
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.27%
EPS Next Y270.09%
EPS Next 2Y183.08%
EPS Next 3Y104.94%
EPS Next 5Y89.23%
Revenue 1Y (TTM)114.3%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.39%
Revenue Next Year6.2%
Revenue Next 2Y15.2%
Revenue Next 3Y12.29%
Revenue Next 5Y12.12%
EBIT growth 1Y660.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year134.05%
EBIT Next 3Y50.95%
EBIT Next 5Y38.1%
FCF growth 1Y770.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2321.04%
OCF growth 3YN/A
OCF growth 5YN/A

MAC COPPER LTD / MTAL Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for MAC COPPER LTD?

ChartMill assigns a fundamental rating of 3 / 10 to MTAL.


What is the valuation status of MAC COPPER LTD (MTAL) stock?

ChartMill assigns a valuation rating of 6 / 10 to MAC COPPER LTD (MTAL). This can be considered as Fairly Valued.


What is the profitability of MTAL stock?

MAC COPPER LTD (MTAL) has a profitability rating of 2 / 10.


What is the financial health of MAC COPPER LTD (MTAL) stock?

The financial health rating of MAC COPPER LTD (MTAL) is 2 / 10.